| 4H-Thieno[3,2-b]pyrrole-5-carboxylic acid | IC50 | 11.9 [1] |
| 4H-Thieno[3,2-b]pyrrole-5-carboxylic acid | Ki | 3.5 [1] |
| Benzoic acid | IC50 | 2089.3 [1], 65700.0 [2], 134000.0 [3] |
| Benzoic acid | Ki | 2000.0 [1], 7000.0 [2], 10900.0 [3], 54000.0 [4] |
| 4H-Furo[3,2-b]pyrrole-5-carboxylic acid | IC50 | 9.0 [1], 17.2 [2], 141.0 [3], 214.0 [4] |
| 4H-Furo[3,2-b]pyrrole-5-carboxylic acid | Ki | 35.5 [1] |
| 6-[2-(3,5-Difluorophenyl)ethyl]-4-hydroxypyridazin-3(2H)-one | IC50 | 1.5 [1], 7.0 [2], 11.0 [3] |
| 3-Hydroxy-5-(2-Phenylethyl)pyridin-2(1h)-One | IC50 | 3.9 [1], 20.0 [2], 140.0 [3] |
| 6-[2-(3-Fluorophenyl)ethyl]-4-hydroxypyridazin-3(2H)-one | IC50 | 1.4 [1], 6.0 [2], 9.7 [3] |
| 4-Hydroxy-6-{2-[3-(trifluoromethyl)phenyl]ethyl}pyridazin-3(2H)-one | IC50 | 2.4 [1], 8.3 [2], 16.0 [3] |
| 6-[2-(4-Chlorophenyl)ethyl]-4-hydroxypyridazin-3(2H)-one | IC50 | 2.7 [1], 6.3 [2], 13.0 [3] |
| 6-[2-(4-Fluorophenyl)ethyl]-4-hydroxypyridazin-3(2H)-one | IC50 | 3.1 [1], 7.2 [2], 10.0 [3] |
| 4-Hydroxy-6-{2-[2-(trifluoromethyl)phenyl]ethyl}pyridazin-3(2H)-one | IC50 | 8.4 [1], 14.0 [2], 45.0 [3] |
| 6-[2-(2-Fluorophenyl)ethyl]-4-hydroxypyridazin-3(2H)-one | IC50 | 2.0 [1], 4.4 [2], 13.0 [3] |
| 6-(2-Cyclohexylethyl)-4-hydroxypyridazin-3(2H)-one | IC50 | 4.7 [1], 9.8 [2], 10.0 [3], 31.0 [4] |
| 4-Hydroxy-6-(1-phenylethyl)pyridazin-3(2H)-one | IC50 | 4.9 [1], 11.0 [2], 32.0 [3] |
| Unii-76IC00yrvr | IC50 | 12.0 [1], 19.0 [2], 27.0 [3] |
| 3-Hydroxyquinolin-2(1h)-One | IC50 | 4.0 [1], 6.9 [2], 42.0 [3], 43.0 [4] |
| 6-Chlorobenzo[d]isoxazol-3-ol | IC50 | 17.2 [1], 27.0 [2], 110.0 [3], 507.0 [4] |
| 6-{2-[3,5-Bis(Trifluoromethyl)phenyl]ethyl}-4-hydroxy-2,3-dihydropyridazin-3-one | IC50 | 57.0 [1], 63.0 [2], 250.0 [3] |
| 6-(Phenoxymethyl)-1,2-dihydropyridazine-3,4-dione | IC50 | 2.2 [1], 5.1 [2] |
| 3-Hydroxycoumarin | IC50 | 34.67 [1] |
| 3-Hydroxycoumarin | Ki | 13.0 [1], 156.0 [2] |
| 5-Methyl-1H-pyrazole-3-carboxylic acid | IC50 | 473.0 [1], 910.0 [2] |
| 4-(4-Chlorophenethyl)-1H-pyrrole-2-carboxylic acid | IC50 | 11.48 [1], 238.0 [2] |
| 4-(4-Chlorophenethyl)-1H-pyrrole-2-carboxylic acid | Ki | 7.2 [1] |
| 3-Hydroxy-6-(2-Phenylethyl)pyridazin-4(1h)-One | IC50 | 2.4 [1], 3.8 [2], 10.0 [3] |
| 6-(3-Phenylpropyl)-1,2-dihydropyridazine-3,4-dione | IC50 | 13.0 [1], 233.0 [2] |
| 6-[2-(2,4-Difluorophenyl)ethyl]-4-hydroxypyridazin-3(2H)-one | IC50 | 2.2 [1], 5.5 [2], 13.0 [3] |
| Malonic acid | IC50 | 10000000.0 [1] |
| 3-Hydroxycinnamic acid | IC50 | 6269000.0 [1], 10000000.0 [2] |
| 3-Thiophenecarboxylic acid | IC50 | 4400.0 [1] |
| 3-Thiophenecarboxylic acid | Ki | 8160.0 [1] |
| Crotonic acid | IC50 | 357000.0 [1], 598000.0 [2] |
| 5-Chloro-2,3-pyridinediol | IC50 | 47.0 [1], 930.0 [2] |
| 5-Aminonicotinic acid | IC50 | 2500000.0 [1] |
| 4,5,6,7-Tetrahydrobenzo[b]thiophene-2-carboxylic acid | IC50 | 900000.0 [1], 1450000.0 [2] |
| 5-Phenyl-1,3,4-oxadiazol-2-ol | IC50 | 253000.0 [1], 365000.0 [2] |
| 5-Chloro-3-hydroxyquinolin-2(1H)-one | IC50 | 4.0 [1], 9.0 [2] |
| 2-(Naphthalen-1-ylmethyl)-1,2,4-triazinane-3,5,6-trione | IC50 | 50.0 [1] |
| 2-(Naphthalen-1-ylmethyl)-1,2,4-triazinane-3,5,6-trione | Ki | 60.0 [1] |
| 5-Chloro-6-fluoro-3-hydroxyquinolin-2(1H)-one | IC50 | 5.0 [1], 8.2 [2] |
| 5,6-Dihydro-4H-cyclopenta[b]thiophene-2-carboxylic acid | IC50 | 59800.0 [1] |
| 5,6-Dihydro-4H-cyclopenta[b]thiophene-2-carboxylic acid | Ki | 9920.0 [1] |
| 5-(2-Methylphenyl)-3H-1,3,4-oxadiazol-2-one | IC50 | 199000.0 [1], 298000.0 [2] |
| 5,6-Dichloro-1,2-benzoxazol-3-ol | IC50 | 3.09 [1] |
| 5,6-Dichloro-1,2-benzoxazol-3-ol | Ki | 1.7 [1] |
| 4-Ethyl-5-propylthiophene-2-carboxylic acid | IC50 | 7905000.0 [1], 10000000.0 [2] |
| 4-Ethyl-5-methylthiophene-2-carboxylic acid | IC50 | 666000.0 [1], 1104000.0 [2] |
| 5-Methyl-4-propylthiophene-2-carboxylic acid | IC50 | 1832000.0 [1], 3725000.0 [2] |
| 3-(2-Phenylethyl)-4H-furo[3,2-b]pyrrole-5-carboxylic acid | IC50 | 218.78 [1] |
| 3-(2-Phenylethyl)-4H-furo[3,2-b]pyrrole-5-carboxylic acid | Ki | 190.0 [1] |
| 6-[(E)-2-(4-Chlorophenyl)ethenyl]-1,2-dihydropyridazine-3,4-dione | IC50 | 120.0 [1], 570.0 [2] |
| 6-Cyclohexyl-1,2-dihydropyridazine-3,4-dione | IC50 | 300.0 [1], 1000.0 [2] |
| 6-(3,3-Dimethylbutyl)-1,2-dihydropyridazine-3,4-dione | IC50 | 670.0 [1], 1000.0 [2] |
| 6-[2-(3-Methoxyphenyl)ethyl]-1,2-dihydropyridazine-3,4-dione | IC50 | 2.1 [1], 8.8 [2] |
| 6-[2-(3,5-Dimethoxyphenyl)ethyl]-1,2-dihydropyridazine-3,4-dione | IC50 | 13.0 [1], 25.0 [2] |
| 6-[2-(4-Methoxyphenyl)ethyl]-1,2-dihydropyridazine-3,4-dione | IC50 | 2.9 [1], 10.0 [2] |
| 2-Methyl-1,2,4-triazinane-3,5,6-trione | IC50 | 2800.0 [1], 3100.0 [2] |
| 6-[(E)-2-Phenylethenyl]-1,2-dihydropyridazine-3,4-dione | IC50 | 2.4 [1], 3.8 [2] |
| 6-[(2-Fluorophenoxy)methyl]-1,2-dihydropyridazine-3,4-dione | IC50 | 3.5 [1], 8.9 [2] |
| 6-[2-[3-(Hydroxymethyl)phenyl]ethyl]-1,2-dihydropyridazine-3,4-dione | IC50 | 2.1 [1], 8.8 [2] |
| 6-[2-[4-(Hydroxymethyl)phenyl]ethyl]-1,2-dihydropyridazine-3,4-dione | IC50 | 2.9 [1], 10.0 [2] |
| 6-[2-[3-(Hydroxymethyl)-5-methoxyphenyl]ethyl]-1,2-dihydropyridazine-3,4-dione | IC50 | 13.0 [1], 25.0 [2] |
| 6-[2-(4-Tert-butylphenyl)ethyl]-1,2-dihydropyridazine-3,4-dione | IC50 | 6.6 [1], 18.0 [2] |
| 6-[[4-(Hydroxymethyl)phenyl]sulfanylmethyl]-1,2-dihydropyridazine-3,4-dione | IC50 | 5.2 [1], 12.0 [2] |
| 6-[(4-Fluorophenoxy)methyl]-1,2-dihydropyridazine-3,4-dione | IC50 | 2.9 [1], 13.0 [2] |
| 6-[(3-Fluorophenoxy)methyl]-1,2-dihydropyridazine-3,4-dione | IC50 | 2.3 [1], 13.0 [2] |
| 6-[2-[4-(3,3-Difluoroprop-1-ynyl)phenyl]ethyl]-1,2-dihydropyridazine-3,4-dione | IC50 | 8.1 [1], 18.0 [2] |
| 6-[2-(4-Methylphenyl)ethyl]-1,2-dihydropyridazine-3,4-dione | IC50 | 6.1 [1], 14.0 [2] |
| 6-[2-(4-Phenylphenyl)ethyl]-1,2-dihydropyridazine-3,4-dione | IC50 | 1.2 [1], 16.0 [2] |
| 6-[2-(3-Methylphenyl)ethyl]-1,2-dihydropyridazine-3,4-dione | IC50 | 2.5 [1], 4.6 [2] |
| 6-[2-(2-Methylphenyl)ethyl]-1,2-dihydropyridazine-3,4-dione | IC50 | 3.3 [1], 8.4 [2] |
| 6-(2-Naphthalen-1-ylethyl)-1,2-dihydropyridazine-3,4-dione | IC50 | 2.3 [1], 8.8 [2] |
| 6-(4-Phenylbutyl)-1,2-dihydropyridazine-3,4-dione | IC50 | 2.5 [1], 11.0 [2] |
| 3(2H)-Pyridazinone, 6-butyl-4-hydroxy- | IC50 | 6.9 [1], 13.0 [2] |
| Norepinephrine | IC50 | 10000000.0 [1] |
| Nicotinic acid | IC50 | 1125000.0 [1] |
| Ceftriaxone | IC50 | 10000.0 [1] |
| Kojic acid | IC50 | 2000.0 [1] |
| 2-Thiophenecarboxylic acid | IC50 | 7800.0 [1] |
| 3-Aminobenzoic acid | IC50 | 392000.0 [1] |
| 3-Aminopyridine | IC50 | 10000000.0 [1] |
| Pyrrole-2-carboxylic acid | IC50 | 5000.0 [1] |
| 2,3-Dihydroxypyridine | IC50 | 1150.0 [1] |
| Indole-2-carboxylic acid | IC50 | 745.0 [1] |
| 3-Hydroxypicolinic acid | IC50 | 2478000.0 [1] |
| 2-Hydroxybenzimidazole | IC50 | 100000.0 [1] |
| Mofegiline | IC50 | 10000.0 [1] |
| 5-Chlorosalicylic acid | IC50 | 3671000.0 [1] |
| Mesotartaric acid | IC50 | 10000000.0 [1] |
| Adrenalone | IC50 | 1000000.0 [1] |
| 5-Fluorosalicylic acid | IC50 | 1045000.0 [1] |
| 2-Aminonicotinic acid | IC50 | 1000000.0 [1] |
| 3-Aminopicolinic acid | IC50 | 1000000.0 [1] |
| 3-Hydroxyindolin-2-one | IC50 | 100000.0 [1] |
| 6-Aminonicotinic acid | IC50 | 2500000.0 [1] |
| Benzo[d]isoxazol-3-ol | IC50 | 418.0 [1] |
| 5-Hydroxynicotinic acid | IC50 | 10000000.0 [1] |
| 7-Chloroisatin | IC50 | 7870.0 [1] |